Search

Your search keyword '"Smith, A.D."' showing total 767 results

Search Constraints

Start Over You searched for: Author "Smith, A.D." Remove constraint Author: "Smith, A.D."
767 results on '"Smith, A.D."'

Search Results

13. Machine learning did not beat logistic regression in time series prediction for severe asthma exacerbations

15. 437TiP An open-label, multicenter, phase II study to evaluate the safety and efficacy of BB-1701, a novel antibody drug conjugate (ADC) targeting HER2, in previously treated patients (pts) with HER2+ or HER2-low unresectable or metastatic (M) breast cancer (BC)

17. Global urban environmental change drives adaptation in white clover

21. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

23. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

24. Type 1 diabetes in pregnancy is associated with distinct changes in the composition and function of the gut microbiome.

30. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease

31. Plasma vitamin B12 status and cerebral white-matter lesions

35. Apolipoprotein E (sub epsilon)4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference: the Hordaland Health Study

36. Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease

37. Frequency-domain SQUID multiplexing of transition-edge sensors

38. A frequency-domain SQUID multiplexer for arrays of transition-edge superconducting sensors

39. Measurement and analysis of brain deformation during neurosurgery

43. Measures of folding applied to the development of the human fetal brain

44. Descartes and the Late Scholastics

45. O'Shaughnessy's consciousness

46. Perception and belief

49. 710P Phase II trial of lenvatinib (LEN) + pembrolizumab (PEMBRO) for progressive disease after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell (mcc) renal cell carcinoma (RCC): Results by independent imaging review and subgroup analyses

50. LBA44 Lenvatinib (len) plus pembrolizumab (pembro) for advanced melanoma (MEL) that progressed on a PD-1 or PD-L1 inhibitor: Initial results of LEAP-004

Catalog

Books, media, physical & digital resources